27 April 2021
: Case report
A Rare Case of Pembrolizumab-Induced Dermatomyositis in a Patient with Cancer of Unknown Primary Origin
Challenging differential diagnosis, Unusual or unexpected effect of treatment, Diagnostic / therapeutic accidents, Unexpected drug reaction, Rare disease
Kensaku Takatsuki1AEF, Toyoshi Yanagihara2ADEF*, Ayaka Egashira2E, Naruhiko Ogo2E, Seiji Yoshizawa1DE, Syunya Sunami3D, Tatsuma Asoh2D, Takashige Maeyama2ADFGDOI: 10.12659/AJCR.930286
Am J Case Rep 2021; 22:e930286
Related articles
Coming soon...
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.944817
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946074
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946165
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946414
Most Viewed Current Articles
21 Jun 2024 : Case report
89,097
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
50,223
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133
20 Nov 2023 : Case report
25,750
DOI :10.12659/AJCR.941424
Am J Case Rep 2023; 24:e941424
18 Feb 2024 : Case report
22,690
DOI :10.12659/AJCR.943030
Am J Case Rep 2024; 25:e943030